Post by Dr. Julita Panek
Senior Advisor Pharma R&D Transformation bei Siemens Advanta | Biotechnologie, Biowissenschaften
๐๐Last weekโs ๐๐ข๐จ๐ญ๐๐๐ก ๐๐ฎ๐ฆ๐ฆ๐ข๐ญ ๐๐ฎ๐ฌ๐ญ๐ซ๐ข๐ ๐ข๐ง ๐๐ซ๐๐ณ was truly memorable. Still energized. Still inspired. Still dancing (at least in my head). ๐ This summit was a celebration of ๐๐จ๐ง๐ง๐๐๐ญ๐ข๐จ๐ง, ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง, and ๐๐จ-๐๐ซ๐๐๐ญ๐ข๐จ๐ง - and a clear signal for the future of biotech in Austria ๐ฆ๐น and Europe ๐ช๐บ. What stayed with me: โจ Talks that inspired โ beyond the slides ๐ง Panels that sparked real thought โ and even more questions ๐ค 1:1 meetings that turned into meaningful connections ๐ฟ Local charm โ wine, nature & hospitality (thank you, ZETA) ๐ Joy, laughter, dancing โ because good energy drives good outcomes. What truly moved me: the authentic ๐ฅ๐๐๐๐๐ซ๐ฌ๐ก๐ข๐ฉ of Lejla Pock, Peter Llewellyn-Davies and Klaus Weinberger showing how joyful professionalism can turn ๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐จ๐ง ๐ข๐ง๐ญ๐จ ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง. ๐ก My key takeaway: Biotech is a high-risk, high-impact industry โ and real progress happens when we connect the dots across silos. ๐ ๐ซ๐จ๐ฆ ๐๐๐ซ๐ฅ๐ฒ ๐&๐ ๐ญ๐จ ๐ฆ๐๐ง๐ฎ๐๐๐๐ญ๐ฎ๐ซ๐ข๐ง๐ . ๐ ๐ซ๐จ๐ฆ ๐๐๐ญ๐ ๐ญ๐จ ๐ฆ๐๐๐ข๐๐ข๐ง๐.๐โก๏ธโค๏ธ In my new role at Siemens Advanta, I reflected on how we can support this journey: ๐ End-to-end integration across the product & process lifecycle ๐ Data connectivity, contextualization & integrated IT architecture in early-stage research ๐ Simplifying systems access for CROs working across multiple tools ๐ Speeding up tech transfer โ with strong data security & client confidentiality at CDMOs ๐ Co-creating smart workflows to streamline patient data entry and ease clinical studdies evaluation. When we have the courage to embrace change, new ideas, and new technologies โ we can build a kind of ๐๐ข๐ฅ๐ข๐๐จ๐ง ๐๐๐ฅ๐ฅ๐๐ฒ ๐๐จ๐ซ ๐๐ข๐จ๐ญ๐๐๐ก. ๐ ๐ Thank you,ย Harpreet Singh for your powerful reminder of ๐๐๐ we do this: ๐ ๐จ๐ซ ๐ญ๐ก๐ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ. Maybe even for our families.ย For more life. For better life. Itโs an honor to be part of this mission. ๐ฌ What challenges are you facing in biotech right now? Letโs talk and exchange maybe in ๐๐ข๐ฏ๐ข๐ง๐ ๐๐๐ @ Siemens in Vienna and meet again in ๐๐ง๐ง๐ฌ๐๐ซ๐ฎ๐๐ค ๐ข๐ง ๐๐๐ญ๐จ๐๐๐ซ ๐๐๐๐! Sophie Zettl, Nicole Daniela Schlautmann, Dr. Christoph Klade, Jason Golan, Michaela Vancova, Christina Guttmann-Gruber, Hana Cernecka, Barbara Prietl, Jochen Bergmann, Matthias Mรผllner, Isabel Prammer, Patrik Frei, Georg Altenbacher Marc J. Brehme, PhD, MBA Georg Sachs #BiotechAustria #HumanTechnologyStyria #HealthHubTriol #Austria #Europe #Innovation #Collaboration #Ecosystem #Startup #CRO #CDMO #Investor #PatentAttorney